Klaus Edvardsen
Corporate Officer/Principal en NYKODE THERAPEUTICS .
Perfil
Klaus Edvardsen is currently the Chief Development Officer at Nykode Therapeutics ASA since 2022.
Prior to this, he was the Chief Development Officer at CureVac NV from 2021 to 2022.
He also served as the SVP& Head-Global Medicines Development Oncology at AstraZeneca PLC.
Dr. Edvardsen holds a doctorate degree from the University of Copenhagen.
Cargos activos de Klaus Edvardsen
| Empresas | Cargo | Inicio |
|---|---|---|
| NYKODE THERAPEUTICS | Corporate Officer/Principal | 01/07/2022 |
Antiguos cargos conocidos de Klaus Edvardsen.
| Empresas | Cargo | Fin |
|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 30/06/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formación de Klaus Edvardsen.
| University of Copenhagen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CUREVAC N.V. | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
- Bolsa de valores
- Insiders
- Klaus Edvardsen